2-151666286-C-G
Variant summary
Our verdict is Uncertain significance. The variant received 3 ACMG points: 3P and 0B. PM2PP3
The NM_001164507.2(NEB):c.4835G>C(p.Arg1612Pro) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000186 in 1,613,784 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R1612H) has been classified as Likely benign.
Frequency
Consequence
NM_001164507.2 missense
Scores
Clinical Significance
Conservation
Publications
- nemaline myopathy 2Inheritance: AR, AD Classification: DEFINITIVE, STRONG, LIMITED Submitted by: ClinGen, Labcorp Genetics (formerly Invitae), Myriad Women’s Health, G2P, Ambry Genetics
 - childhood-onset nemaline myopathyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
 - intermediate nemaline myopathyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
 - typical nemaline myopathyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
 - lethal multiple pterygium syndromeInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
 - severe congenital nemaline myopathyInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
 
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 3 ACMG points.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt | 
|---|---|---|---|---|---|---|---|---|---|---|
| NEB | ENST00000397345.8  | c.4835G>C | p.Arg1612Pro | missense_variant | Exon 41 of 182 | 5 | NM_001164508.2 | ENSP00000380505.3 | ||
| NEB | ENST00000427231.7  | c.4835G>C | p.Arg1612Pro | missense_variant | Exon 41 of 182 | 5 | NM_001164507.2 | ENSP00000416578.2 | ||
| NEB | ENST00000409198.5  | c.4835G>C | p.Arg1612Pro | missense_variant | Exon 41 of 150 | 5 | ENSP00000386259.1 | 
Frequencies
GnomAD3 genomes   AF:  0.00000657  AC: 1AN: 152116Hom.:  0  Cov.: 32 show subpopulations 
GnomAD4 exome  AF:  0.00000137  AC: 2AN: 1461668Hom.:  0  Cov.: 31 AF XY:  0.00000275  AC XY: 2AN XY: 727124 show subpopulations 
Age Distribution
GnomAD4 genome   AF:  0.00000657  AC: 1AN: 152116Hom.:  0  Cov.: 32 AF XY:  0.0000135  AC XY: 1AN XY: 74306 show subpopulations 
Age Distribution
ClinVar
Submissions by phenotype
Nemaline myopathy 2    Uncertain:1 
This sequence change replaces arginine with proline at codon 1612 of the NEB protein (p.Arg1612Pro). The arginine residue is moderately conserved and there is a moderate physicochemical difference between arginine and proline. This variant is not present in population databases (ExAC no frequency). This variant has not been reported in the literature in individuals with NEB-related conditions. Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Not Available"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Computational scores
Source: 
Splicing
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at